Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seonaid Nolan

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Drug and Alcohol Dependence Reports|May 1, 2026
U<b>se of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case serie</b>sAlexander Wong, Seonaid Nolan, Paxton Bach, et al.
Addiction Science & Clinical Practice|May 1, 2026
Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluationSidney Roberge, Seonaid Nolan, Cheyenne Johnson, et al.
Contemporary Clinical Trials|October 6, 2023
Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: A pragmatic randomized delay trialRita K McCracken, Shawna Narayan, Malcolm Maclure, et al.
Drug and Alcohol Dependence|June 1, 2025
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020Elise Jackson, Paxton Bach, M Eugenia Socias, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Annals of Emergency Medicine|August 2, 2020
Lorazepam Versus Diazepam in the Management of Emergency Department Patients With Alcohol WithdrawalFrank X Scheuermeyer, Isabelle Miles, Daniel J Lane, et al.
Addiction (Abingdon, England)|October 13, 2020
Risk of overdose-related death for people with a history of incarcerationWen Qi Gan, Stuart A Kinner, Tonia L Nicholls, et al.
Drug and Alcohol Dependence Reports|August 21, 2025
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort studyPaige Guyatt, Glenda Babe, Anastasia Gayowsky, et al.
BMJ Open|October 15, 2025
Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational studyMegan Kurz, B Carolina Guerra-Alejos, Md Belal Hossain, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Drug and Alcohol Dependence Reports|May 1, 2026
U<b>se of benzodiazepines and medications for opioid use disorder for withdrawal management in a hospital-based setting for individuals exposed to benzodiazepine-contaminated fentanyl: A case serie</b>sAlexander Wong, Seonaid Nolan, Paxton Bach, et al.
Addiction Science & Clinical Practice|May 1, 2026
Patient experiences and perceived efficacy of a newly implemented hospital-based withdrawal management unit in Vancouver, Canada: findings from the Road to Recovery evaluationSidney Roberge, Seonaid Nolan, Cheyenne Johnson, et al.
Contemporary Clinical Trials|October 6, 2023
Evaluation of audit and feedback to family physicians on prescribing of opioid analgesics to opioid-naïve patients: A pragmatic randomized delay trialRita K McCracken, Shawna Narayan, Malcolm Maclure, et al.
Drug and Alcohol Dependence|June 1, 2025
Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: Findings from a prospective cohort study from 2013 to 2020Elise Jackson, Paxton Bach, M Eugenia Socias, et al.
Substance Abuse Treatment, Prevention, and Policy|February 21, 2024
An emergency-department-initiated outreach program for patients with opioid use disorder is associated with an increase in agonist therapy and engagement in addictions care: a one-year cohort studyRukaiyah Lakkadghatwala, Daniel Lane, Frank Scheuermeyer, et al.
CJEM|August 22, 2023
Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packsKevin Duncan, Frank Scheuermeyer, Daniel Lane, et al.
Annals of Emergency Medicine|August 2, 2020
Lorazepam Versus Diazepam in the Management of Emergency Department Patients With Alcohol WithdrawalFrank X Scheuermeyer, Isabelle Miles, Daniel J Lane, et al.
Addiction (Abingdon, England)|October 13, 2020
Risk of overdose-related death for people with a history of incarcerationWen Qi Gan, Stuart A Kinner, Tonia L Nicholls, et al.
Drug and Alcohol Dependence Reports|August 21, 2025
Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort studyPaige Guyatt, Glenda Babe, Anastasia Gayowsky, et al.
BMJ Open|October 15, 2025
Comparative effectiveness of take-home dosing schedules for opioid agonist treatment in British Columbia, Canada: a target trial emulation protocol using a population-based observational studyMegan Kurz, B Carolina Guerra-Alejos, Md Belal Hossain, et al.
Pageof 12